XIFIN - Crunchbase Company Profile & Funding

Q: Where is XIFIN's headquarters?

XIFIN is located in San Diego, California, United States.

Q: Who invested in XIFIN?

XIFIN has 5 investors including Goldman Sachs And Avista Healthcare Partners.

Q: When was the last funding round for XIFIN?

XIFIN closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

XIFIN

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About XIFIN

CB Rank

49288

XIFIN is a health information technology company that leverages diagnostic information to improve the quality and economics of healthcare.

Acquired by

GTCR

Founded

obfuscation

Private

Venture - Series Unknown

San Diego, California, United States

501-1000

www.xifin.com

Enterprise Software

Health Care

Health Diagnostics

Information Technology

Medical Device

Software

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series D

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Jeffrey Yates: CTO
Past Role: CSC, Manager and Developer
Mitchell Fry: Vice President - Sales and Strategic Alliances

Details

Legal Name

XiFin, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Lale White

About the Company

XIFIN is a health information technology company that leverages diagnostic information to improve the quality and economics of healthcare. The XIFIN technology platform facilitates connectivity and workflow automation for accessing and sharing clinical and financial diagnostic data, linking healthcare stakeholders in the delivery and reimbursement

of care. The company has received continual industry recognition, including being named to the Inc. 5000 fastest growing privately-held companies 2007 through 2010, and ranking among Deloitte's Technology Fast 500. For more information visit www.xifin.com.

Phone Number

858-793-5700

Contact Email

marketinginfo@xifin.com

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Insight

See this Growth Insight

XIFIN is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

XiFin RPM

A SaaS-based revenue cycle management (RCM) platform designed for high-volume medical billing environments, optimizing billing and accounts receivable processes.

APIs and Web Services

Provides a range of APIs for encounter/accession/visit management, patient demographics, client management, payor details, eligibility checks, file maintenance, electronic payments, and patient estimation.

Research & Development

XIFIN is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - XIFIN	2	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Goldman Sachs	Yes	Venture Round - XIFIN	Marc Boheim
Goldman Sachs	Yes	Venture Round - XIFIN	Marc Boheim
Goldman Sachs	Yes	Venture Round - XIFIN	Marc Boheim
Goldman Sachs	Yes	Venture Round - XIFIN	Marc Boheim
Goldman Sachs	Yes	Venture Round - XIFIN	Marc Boheim

Investments

Investment Breakdown

Number of Acquisitions

Investment Breakdown

Number of Acquisitions

M&A Details

XIFIN

was acquired by

GTCR

obfuscation

Transaction Name

XIFIN acquired by GTCR

Acquired by

GTCR

Announced Date

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

501-1000

Employee Profiles

Board Members and Advisors

Contacts

359

Employee Profiles

Jeffrey Yates CTO
Mitchell Fry Vice President - Sales and Strategic Alliances
Rina Wolf Vice President, Strategic Commercialization, Consulting & Industry Affairs
Mike Coats Executive VP